As increasing regulatory and scientific complexities threaten R&D productivity, you need a bioanalytical laboratory and ADME partner who can truly enhance the drug development process. IQVIA Laboratories operates one of the world's largest and most respected bioanalytical laboratory networks. Drawing on 20+ years of experience, we have developed numerous robust methods used to deliver the vital data you need. Beyond those listed, we can also develop customized methods to meet your specific challenge.
Download our validated bioanalytical methods list to learn how we deliver consistent, reliable data.
Download Document
Related Insights
ADME Services
Accelerating your drug discovery, preclinical and clinical programs
Bioanalytical Automation of Samples
Taking an assay from bench to an automated platform
Automation within an ADME Laboratory
Taking an assay from bench to an automated platform
Bioanalytical Automation of Samples
Taking an assay from bench to an automated platform
Developing Assays for Novel Drugs
Current science regarding hybrid assays, why they are considered the next "big thing," the technical challenges, and the regulatory impact of these assays.
Strategies for Effective Neutralizing Cell Based Assays in Early Immunogenicity Risk Assessment
Quantitative Assays for Peptides using LC-MS
Quantitative high-throughput analysis of peptide therapeutics and biomarkers to regulated bioanalytical standards
Hybrid Assays for Protein Bioanalysis
Combining immuno-affinity with liquid chromatography-mass spectrometry (LC-MS)
Absolute Bioavailability Analysis Using Stable Isotopes
A Liquid Chromatography-Tandem Mass Spectrometry Approach
Bioanalysis for Immuno Oncology with Mike Brown
I-O clinical development podcast series
